|
Mouse Strain information
|
||||||||||||||||||||||||
| APB ID | 5385 | |||||||||||||||||||||||
| Added | 14/01/2011 | |||||||||||||||||||||||
| Last Edited | 02/05/2019 | |||||||||||||||||||||||
| Strain nomenclature: | B6;129P2-Ndufs6Gt(AR0138)Wtsi/MrchApb | |||||||||||||||||||||||
| Nickname: | WOMBAT ; Ndufs6gt/+ | |||||||||||||||||||||||
| Strain designation name: | B6;129P2-Ndufs6Gt(AR0138)Wtsi/MrchApb | |||||||||||||||||||||||
|
Genetics
|
||||||||||||||||||||||||
| Genetic Details |
Gene trap
|
|||||||||||||||||||||||
| ES Cell-Line Used | AR0138 | |||||||||||||||||||||||
| Mode of Inheritance | Recessive | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Mutant Construction Technique | None | |||||||||||||||||||||||
|
Phenotype
|
||||||||||||||||||||||||
| Phenotype Homozygous State | Ndufs6gt/gt mice are fertile. For the first 4 months of life, Ndufs6gt/gt mice have no overt phenotype, with normal weight gain and survival. After 4 months of age, Ndufs6gt/gt mice develop cardiac hypertrophy, which can lead to sudden weight loss, lethargy and death. Ndufs6gt/gt males are more severely affected than females. | |||||||||||||||||||||||
| Phenotype Heterozygous State | Normal | |||||||||||||||||||||||
| Original Genetic Background | 129P2/OlaHsd x C57BL/6N | |||||||||||||||||||||||
| Genetic Background Currently Maintained | 129P2/OlaHsd x C57BL/6N | |||||||||||||||||||||||
|
Strain identification
|
||||||||||||||||||||||||
| How is this strain characterised? |
Genotyping
|
|||||||||||||||||||||||
|
Fertility and Strain maintenance
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
Relevant bibliographic / database references
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
General information
|
||||||||||||||||||||||||
| Other Patent Technologies? | No | |||||||||||||||||||||||
| Associated IP rights? | No | |||||||||||||||||||||||
| Does it Model a Human Condition? | Yes | |||||||||||||||||||||||
| Description of human condition: | Mutations in human gene, NDUFS6, encoding one of the 45 subunits of Complex I, are one cause of Complex I deficiency. NDUFS6-/- patients suffer from seizures, hypotonia and abnormal eye movements and die in the first month of life. Currently, no effective treatment is available. | |||||||||||||||||||||||
| Research value of this Strain | Mutations in human gene cause lethal infantile mitochondrial disease. The mice exhibit different degrees of Complex I deficiency in various tissues, especially in the heart. Treatment of mitochondrial disorders is currently inadequate. We believe this is a very useful model for the study of cardiac myopathy and for investigating new treatment strategies. | |||||||||||||||||||||||
| Applicable Research Areas |
Models for human disease
Cardiovascular |
|||||||||||||||||||||||
| Keywords |
|
|||||||||||||||||||||||
| Is the strain available in any form to other researchers | Possibly | |||||||||||||||||||||||
| APB stock stored as: |
Cryopreserved sperm (from 5 mice)
|
|||||||||||||||||||||||
| Are live mice available? | Limited | |||||||||||||||||||||||
| MTA needs to be signed? | Yes | |||||||||||||||||||||||
